Literature DB >> 20570675

Plasticity of postsynaptic, but not presynaptic, GABAB receptors in SSADH deficient mice.

Irina Vardya1, Kim R Drasbek, K Michael Gibson, Kimmo Jensen.   

Abstract

Succinic semialdehyde dehydrogenase (SSADH) deficiency is an autosomal-recessively inherited disorder of gamma-aminobutyrate (GABA) catabolism characterized by ataxia and epilepsy. Since SSADH is responsible for GABA break-down downstream of GABA transaminase, patients manifest high extracellular levels of GABA, as well as the GABA(B) receptor (GABA(B)R) agonist gamma-hydroxybutyrate (GHB). SSADH knockout (KO) mice display absence seizures, which progress into lethal tonic-clonic seizures at around 3weeks of age. It is hypothesized that desensitization of GABA(B)Rs plays an important role in the disease, although detailed studies of pre- and postsynaptic GABA(B)Rs are not available. We performed patch-clamp recordings from layer 2/3 pyramidal neurons in neocortical brain slices of wild-type (WT) and SSADH KO mice. Electrical stimulation of GABAergic fibers during wash in of the GABA(B)R agonist baclofen revealed no difference in presynaptic GABA(B)R mediated inhibition of GABA release between WT and SSADH KO mice. In contrast, a significant decrease in postsynaptic baclofen-induced potassium currents was seen in SSADH KO mice. This reduction was unlikely to be caused by accumulation of potassium, GABA or GHB in the brain slices, or an altered expression of regulators of G-protein signaling (RGS) proteins. Finally, adenosine-induced potassium currents were also reduced in SSADH KO mice, which could suggest heterologous desensitization of the G-protein dependent effectors, leading to a reduction in G-protein coupled inwardly rectifying potassium (GIRK) channel responses. Our findings indicate that high GABA and GHB levels desensitize postsynaptic, but not certain presynaptic, GABA(B)Rs, promoting a decrease in GIRK channel function. These changes could contribute to the development of seizures in SSADH KO mice and potentially also in affected patients. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20570675      PMCID: PMC3654531          DOI: 10.1016/j.expneurol.2010.05.022

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  56 in total

1.  A trafficking checkpoint controls GABA(B) receptor heterodimerization.

Authors:  M Margeta-Mitrovic; Y N Jan; L Y Jan
Journal:  Neuron       Date:  2000-07       Impact factor: 17.173

2.  The C-terminal domains of the GABA(b) receptor subunits mediate intracellular trafficking but are not required for receptor signaling.

Authors:  A R Calver; M J Robbins; C Cosio; S Q Rice; A J Babbs; W D Hirst; I Boyfield; M D Wood; R B Russell; G W Price; A Couve; S J Moss; M N Pangalos
Journal:  J Neurosci       Date:  2001-02-15       Impact factor: 6.167

3.  Generalization of amygdala LTP and conditioned fear in the absence of presynaptic inhibition.

Authors:  Hamdy Shaban; Yann Humeau; Cyril Herry; Guillaume Cassasus; Ryuichi Shigemoto; Stephane Ciocchi; Samuel Barbieri; Herman van der Putten; Klemens Kaupmann; Bernhard Bettler; Andreas Lüthi
Journal:  Nat Neurosci       Date:  2006-07-02       Impact factor: 24.884

4.  The GABAB1b isoform mediates long-lasting inhibition of dendritic Ca2+ spikes in layer 5 somatosensory pyramidal neurons.

Authors:  Enrique Pérez-Garci; Martin Gassmann; Bernhard Bettler; Matthew E Larkum
Journal:  Neuron       Date:  2006-05-18       Impact factor: 17.173

5.  Roles of GABAB receptor subtypes in presynaptic auto- and heteroreceptor function regulating GABA and glutamate release.

Authors:  Peter C Waldmeier; Klemens Kaupmann; Stephan Urwyler
Journal:  J Neural Transm (Vienna)       Date:  2008-07-30       Impact factor: 3.575

6.  Constitutive, agonist-accelerated, recycling and lysosomal degradation of GABA(B) receptors in cortical neurons.

Authors:  Thomas Grampp; Valerie Notz; Ilja Broll; Natalie Fischer; Dietmar Benke
Journal:  Mol Cell Neurosci       Date:  2008-10-02       Impact factor: 4.314

Review 7.  Murine succinate semialdehyde dehydrogenase (SSADH) deficiency, a heritable disorder of GABA metabolism with epileptic phenotype.

Authors:  K M Gibson; C Jakobs; P L Pearl; O C Snead
Journal:  IUBMB Life       Date:  2005-09       Impact factor: 3.885

Review 8.  The coupling of neurotransmitter receptors to ion channels in the brain.

Authors:  R A Nicoll
Journal:  Science       Date:  1988-07-29       Impact factor: 47.728

9.  G protein-coupled inwardly rectifying K+ channels (GIRKs) mediate postsynaptic but not presynaptic transmitter actions in hippocampal neurons.

Authors:  C Lüscher; L Y Jan; M Stoffel; R C Malenka; R A Nicoll
Journal:  Neuron       Date:  1997-09       Impact factor: 17.173

10.  Bi-directional effects of GABA(B) receptor agonists on the mesolimbic dopamine system.

Authors:  Hans G Cruz; Tatiana Ivanova; Marie-Louise Lunn; Markus Stoffel; Paul A Slesinger; Christian Lüscher
Journal:  Nat Neurosci       Date:  2004-01-25       Impact factor: 24.884

View more
  8 in total

1.  Methamphetamine-evoked depression of GABA(B) receptor signaling in GABA neurons of the VTA.

Authors:  Claire L Padgett; Arnaud L Lalive; Kelly R Tan; Miho Terunuma; Michaelanne B Munoz; Menelas N Pangalos; José Martínez-Hernández; Masahiko Watanabe; Stephen J Moss; Rafael Luján; Christian Lüscher; Paul A Slesinger
Journal:  Neuron       Date:  2012-03-08       Impact factor: 17.173

2.  GABAB-ergic motor cortex dysfunction in SSADH deficiency.

Authors:  Janine Reis; Leonardo G Cohen; Phillip L Pearl; Brita Fritsch; Nikolai H Jung; Irene Dustin; William H Theodore
Journal:  Neurology       Date:  2012-06-20       Impact factor: 9.910

3.  Effectiveness of nicotinic agonists as desensitizers at presynaptic α4β2- and α4α5β2-nicotinic acetylcholine receptors.

Authors:  Charles R Wageman; Michael J Marks; Sharon R Grady
Journal:  Nicotine Tob Res       Date:  2013-09-19       Impact factor: 4.244

4.  Therapeutic relevance of mTOR inhibition in murine succinate semialdehyde dehydrogenase deficiency (SSADHD), a disorder of GABA metabolism.

Authors:  K R Vogel; G R Ainslie; E E W Jansen; G S Salomons; K M Gibson
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2016-10-17       Impact factor: 5.187

Review 5.  Identifying the role of pre-and postsynaptic GABA(B) receptors in behavior.

Authors:  Chelsea R Kasten; Stephen L Boehm
Journal:  Neurosci Biobehav Rev       Date:  2015-08-15       Impact factor: 8.989

6.  Multiple inhibitory G-protein-coupled receptors resist acute desensitization in the presynaptic but not postsynaptic compartments of neurons.

Authors:  Reagan L Pennock; Matthew S Dicken; Shane T Hentges
Journal:  J Neurosci       Date:  2012-07-25       Impact factor: 6.167

7.  mTOR inhibitors rescue premature lethality and attenuate dysregulation of GABAergic/glutamatergic transcription in murine succinate semialdehyde dehydrogenase deficiency (SSADHD), a disorder of GABA metabolism.

Authors:  Kara R Vogel; Garrett R Ainslie; K Michael Gibson
Journal:  J Inherit Metab Dis       Date:  2016-08-12       Impact factor: 4.982

Review 8.  Succinic semialdehyde dehydrogenase deficiency (SSADHD): Pathophysiological complexity and multifactorial trait associations in a rare monogenic disorder of GABA metabolism.

Authors:  P Malaspina; J-B Roullet; P L Pearl; G R Ainslie; K R Vogel; K M Gibson
Journal:  Neurochem Int       Date:  2016-06-14       Impact factor: 3.921

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.